Titleimage: sitem Center for Translational Medicine and Biomedical Entrepreneurship

The sitem-insel School offers continuing education programs (MAS/DAS/CAS) and standalone courses to specialists in industry, hospitals and academia in the filelds of translational medicine, biomedical entrepreneurship, and medical device regulatory affairs.

The sitem-insel School runs under the roof of the sitem Center for Translational Medicine and Biomedical Entrepreneurship, which is a Center of the Medical Faculty of the University of Bern. Together with the sitem-insel community, the School aims to connect the best minds in Science, Clinical Care, Regulation and Management to advance medical technologies and improve patient care. The School supports individuals in their scientific and entrepreneurial endouvers by offering studies in advanced education (MAS/DAS/CAS) that train specialists in highly relevant topics of translational medicine and entrepreneurship.

Together, we bridge the gap between clinical practice, research, and business.

News

2021/09/02 School, MDRQ

Welcome to the team!

Sarah Schuppli-Saegesser joins our Personalised Medicine Research group.

Sarah is an MSc student in Biomedical Engineering who is currently doing her Master thesis in Biomechanics under the supervision of Johanna Menze. She joins the research group of Dr. Kate Gerber and Dr. Nicolas Gerber. Sarah is currently studying the effects of shoulder muscle strengths on rotator cuff loading, using inverse dynamic analyses in AnyBody.

Sarah studied Physics at the University of Berne and continued as a PhD candidate in Theoretical Astrophysics at the University of Oxford. She subsequently went into teaching Physics at the Gymnasium Biel-Seeland. Sarah has four children (9-13 y.o).

People

Best Communication Award

The Group for Cardiac Technology and Implantable Devices received the Best Communication Award from the Swiss Society of Cardiology for their work "Leadless cardiac resynchronization therapy using conductive intracardiac communication – cumulative experience from in-vivo proof-of-concept trials".

2019/06/20 Awards and distinctions

Vorherige

More News

Events

Best Communication Award

The Group for Cardiac Technology and Implantable Devices received the Best Communication Award from the Swiss Society of Cardiology for their work "Leadless cardiac resynchronization therapy using conductive intracardiac communication – cumulative experience from in-vivo proof-of-concept trials".

2019/06/20 Awards and distinctions

Vorherige

More Events